Pirtobrutinib is a type of BTK inhibitor. It mostly helps with mantle cell lymphoma and CLL. It works by focusing on the BTK signaling pathway—a key part for cancer cells to live and grow.
This comes in tablet form and you can pick from 50 or 100 mg strengths. The usual dose is 200 mg daily, so you just take one tablet a day. Each pack has 60 tabs, so it lasts about a month with the recommended dose.
Doctors keep an eye on how well it works and any side effects while you’re on it.
Reviews
There are no reviews yet.